These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2242548)

  • 1. Calcium channel blockers and progression of coronary artery disease.
    Henry PD
    Circulation; 1990 Dec; 82(6):2251-3. PubMed ID: 2242548
    [No Abstract]   [Full Text] [Related]  

  • 2. Critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertension.
    Tijssen JG; Hugenholtz PG
    Eur Heart J; 1996 Aug; 17(8):1152-7. PubMed ID: 8869855
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-atherosclerotic properties of nifedipine. Benefit of early intervention to prevent cardiovascular complications.
    Rafflenbeul W
    Cardiology; 1997; 88 Suppl 3():52-5. PubMed ID: 9397295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nifedipine in acute coronary syndromes: Furberg's refrain revisited.
    Rafflenbeul W
    Eur Heart J; 1996 Aug; 17(8):1147-52. PubMed ID: 8869854
    [No Abstract]   [Full Text] [Related]  

  • 5. [ACTION study: efficacy of nifedipine in preventing cardiovascular disease in patients with coronary artery disease].
    Shimokawa H
    Drugs; 2006; 66 Spec No 1():10-2. PubMed ID: 18200771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial enhancement of coronary blood flow by nifedipine. Comparison with nitroglycerin and beta blocking agents.
    Engel HJ; Lichtlen PR
    Am J Med; 1981 Oct; 71(4):658-66. PubMed ID: 6792917
    [No Abstract]   [Full Text] [Related]  

  • 7. Post hoc analysis of coronary findings from the prospective randomized evaluation of the vascular effects of the Norvasc trial (PREVENT).
    Mancini GB; Miller ME; Evans GW; Byington R; Furberg CD; Pitt B;
    Am J Cardiol; 2002 Jun; 89(12):1414-6. PubMed ID: 12062738
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium channel blockade in heart failure.
    Guazzi MD; Bartorelli A; Pepi M; Guazzi M
    Cardiologia; 1989 Feb; 34(2):117-25. PubMed ID: 2660989
    [No Abstract]   [Full Text] [Related]  

  • 9. On a possible role for calcium antagonists in atherosclerosis. A personal view.
    Hugenholtz PG; Lichtlen P; van der Giessen W; Becker AE; Nayler WG; Fleckenstein A; Hülsmann WC
    Eur Heart J; 1986 Jul; 7(7):546-59. PubMed ID: 3530767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions that beneficially influence the evolution of coronary atherosclerosis. The case for calcium channel blockers.
    Waters D; Lespérance J
    Circulation; 1992 Dec; 86(6 Suppl):III111-6. PubMed ID: 1424044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiatherogenic effect of nifedipine on intramural small coronary arterial lesions in cholesterol-fed rabbits.
    Kato H; Okada R; Enoki M; Oogushi K; Emura S; Takashima T; Ohmori K
    Angiology; 1998 Jan; 49(1):49-54. PubMed ID: 9456164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel blockers: rationale for their clinical use.
    Conti CR
    J Fla Med Assoc; 1981 Nov; 68(11):883-6. PubMed ID: 6120992
    [No Abstract]   [Full Text] [Related]  

  • 13. [Calcium antagonists in ischemic heart disease].
    Sadowski Z; Kośmicki M; Skorykow-Sapińska A
    Kardiol Pol; 1987; 30 Suppl():44-9. PubMed ID: 3454384
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium-channel blockers for combined systemic hypertension and myocardial ischemia.
    Frishman WH; Charlap S
    Circulation; 1987 Jun; 75(6 Pt 2):V154-62. PubMed ID: 3552312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retardation and arrest of progression or regression of coronary artery disease: a review.
    Vos J; de Feyter PJ; Simoons ML; Tijssen JG; Deckers JW
    Prog Cardiovasc Dis; 1993; 35(6):435-54. PubMed ID: 8497659
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacomodulation of endothelial dysfunction: clinical relevance.
    Dalal JJ
    Indian Heart J; 1999; 51(3):338-41. PubMed ID: 10624080
    [No Abstract]   [Full Text] [Related]  

  • 17. Which calcium channel blocker for ischaemic heart disease?
    Tan K; Lewis S
    Br J Clin Pract; 1992; 46(1):58-62. PubMed ID: 1419556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcium antagonists in cardiological practice].
    Ol'binskaia LI
    Kardiologiia; 1990 Dec; 30(12):100-3. PubMed ID: 2097383
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiischemic properties of amlodipine, a new calcium antagonist, in patients with severe coronary artery disease: a prospective trial.
    Estrada JN; Saglietti H; Di Marco M; Casabé H; Oliveri R
    Am Heart J; 1989 Nov; 118(5 Pt 2):1130-2. PubMed ID: 2530873
    [No Abstract]   [Full Text] [Related]  

  • 20. [ACTION: The clinical study of the month].
    Piérard LA
    Rev Med Liege; 2005 Jan; 60(1):61-3. PubMed ID: 15771319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.